Found 9 matching trials
Efficacy and Safety of JMT103 in the Treatment of Glucocorticoid Induced Osteoporosis PHASE2 This is a randomized, double-blind, double-dummy, positive-controlled phase...
Show More Location
Peking University First Hospital
Learn More & Join Trial
Narlumosbart Compared With Denosumab in Patients With Multiple Myeloma Bone Disease PHASE3 The purpose of this study is to determine if narlumosbart is non-inferior t...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety, Tolerability and PK/PD of JMT103 in Patients With Bone Metastases From Tumors PHASE1 JMT103 is a novel, full human IgG4 monoclonal antibody targeting RANKL. In ...
Show More Location
Shanghai East Hospital
Learn More & Join Trial
Efficacy and Safety of JMT103 in Patients With Giant Cell Tumor of Bone PHASE1 This is a phase Ib/II, multicenter, single-arm, open-label study to evaluat...
Show More Location
Beijing Ji Shui Tan Hospital
Learn More & Join Trial
A Study to Evaluate the Efficacy and Safety of Narlumosbart (JMT103) in Patients With Giant Cell Tumor of Bone PHASE3 This is a phase โ
ข, multi-center, randomized, double-blind, active-controlle...
Show More Location
Beijing Ji Shui Tan Hospital
Learn More & Join Trial
A Clinical Trial to Assess the Efficacy and Safety of JMT103 in Patients With Refractory HCM PHASE1 The purpose of this study is to determine the potential of JMT103 to treat ...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of JMT103 in the Treatment of Postmenopausal Women With Osteoporosis PHASE2 This study is to evaluate the efficacy and safety of JMT103 in the treatmen...
Show More Location
The Second Hospital of Jilin University
Learn More & Join Trial
A Study to Assess the Prevention of Bone-related Events in Patients With Bone Metastases From Malignant Solid Tumors Treated With JMT103 Compared to Zoledronic Acid PHASE3 This is a phase โ
ข, multicenter, randomized, double-blind, study to evaluate...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of JMT103 in Patients With Bone Metastases From Solid Tumors PHASE1 This is a randomized, open-label, dose-finding, multi-centre, phase โ
b stud...
Show More Location
Shanghai East Hospital
Learn More & Join Trial